Adenocarcinoma of the Rectum Completed Phase 1 / 2 Trials for Bevacizumab (DB00112)

IndicationStatusPhase
DBCOND0028688 (Adenocarcinoma of the Rectum)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00307736Bevacizumab, Erlotinib and 5-Fluorouracil With External Beam Radiation Therapy in Locally Advanced Rectal CancerTreatment